PI & SITE INTEREST FORM
Rapid-Acting Treatments for Neuropsychiatric Diseases
See latest data
a rapid-acting neuroplastogen
We are excited to develop new drugs for the millions of people for whom current psychiatric medicines have not worked.
The Latest From Transcend
Fierce Biotech: Psychiatry biotech hopes to Transcend PTSD rivals with new data
TSND-201 (methylone) for PTSD: Initial Results from Open-Label Study (IMPACT-1)
Transcend Therapeutics Announces Positive Open-Label Data from IMPACT-1
Methylone: Distinct Pharmacological and Mechanistic Effects Compared with MDMA
Striving for a world without neuropsychiatric disease.
Because 1 billion patients
Help us bring new mental health solutions to patients
Join us in creating a world free from neuropsychiatric disease.